# Clinical trials recruiting in Mexico: 549 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 549 trials recruiting or not yet recruiting with a site in Mexico, as read on November 19, 2026.

## The full list

Clinical trials recruiting in Mexico: 549 rows for $27.45, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 10 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/country/mexico

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 549
- Recruiting or not yet: 549
- Read on: November 19, 2026

## Trials

The 25 newest of 549, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07940426 | Title: Clinical Performance and Outcomes After Sphere Lens Transition | CooperVision International Limited (CVIL) | Not applicable | Not yet recruiting | Astigmatism | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07940426) |
| November 13, 2026 | NCT07935733 | Blood Biomarkers for Prognostic Stratification in Guillain-Barré Syndrome | Anahuac University | Observational | Recruiting | Guillain Barré Syndrome | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07935733) |
| November 12, 2026 | NCT07930975 | Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular Risk | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Observational | Not yet recruiting | Dyslipidemias, Hypercholesterolemia, Cardiovascular Diseases | 1,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07930975) |
| November 10, 2026 | NCT07929623 | Fluoroscopy-Guided Lumbar Facet Block for Chronic Low Back Pain | ISSSTE Hospital Regional "Gral. Ignacio Zaragoza" | Observational | Not yet recruiting | Chronic Low Back Pain, Lumbar Facet Syndrome | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07929623) |
| November 9, 2026 | NCT07926321 | A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard Treatment | Boehringer Ingelheim | Phase 2 | Not yet recruiting | Idiopathic Pulmonary Fibrosis | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07926321) |
| November 9, 2026 | NCT07924020 | Acute Effects of Rhodiola Rosea and Caffeine on Mean Propulsive Velocity Loss in Resistance Training | Sponsor not shown (see the record) | Not applicable | Not yet recruiting | Muscle Fatigue (C23.888.592.612.612) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07924020) |
| November 4, 2026 | NCT07915219 | A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON) | Boehringer Ingelheim | Phase 3 | Not yet recruiting | Bronchiectasis | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07915219) |
| November 3, 2026 | NCT07911696 | Comparative Effectiveness and Safety of Two Hyaluronic Acid Products in Knee Osteoarthritis | Sponsor not shown (see the record) | Observational | Not yet recruiting | Osteoarthritis, Knee | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911696) |
| November 2, 2026 | NCT07909616 | Respiratory Physiotherapy and Inflammatory Biomarkers in Critically Ill Patients With Pneumonia | Hospital H+ Queretaro | Observational | Recruiting | Pneumonia, Critical Illness | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07909616) |
| October 29, 2026 | NCT07905755 | Effect of HMB Supplementation and Vivifrail Exercise on Body Composition, Handgrip Strength and Physical Performance in Women Over 60 Years... | Universidad Autónoma del Estado de Hidalgo | Not applicable | Not yet recruiting | Aging, Muscle Strength, Physical Functional Performance, Body Composition | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07905755) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 26, 2026 | NCT07893704 | Aortic Size and Height Indices in Abdominal Aortic Aneurysms | Sponsor not shown (see the record) | Observational | Not yet recruiting | Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm, Ruptured, Abdominal Aortic Aneurysm Without Rupture | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07893704) |
| October 22, 2026 | NCT07890025 | CD19 CAR-T Cell Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Phase I/II Study | Hospital Universitario Dr. Jose E. Gonzalez | Phase 1/2 | Not yet recruiting | Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07890025) |
| October 21, 2026 | NCT07886268 | A Study to Evaluate the Efficacy and Safety of TP-06 for PCED | Tarsus Pharmaceuticals, Inc. | Phase 2 | Recruiting | Persistent Corneal Epithelial Defect | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07886268) |
| October 19, 2026 | NCT07881185 | Artificial Intelligence for Brain MRI Analysis in Epilepsy | Istituto Giannina Gaslini | Observational | Recruiting | Epilepsies | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07881185) |
| October 15, 2026 | NCT07875088 | Real-World Outcomes of Drug-Coated Balloon Angioplasty in Coronary Artery Disease | Sponsor not shown (see the record) | Observational | Recruiting | Coronary Artery Disease | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07875088) |
| October 7, 2026 | NCT07863674 | Cardiovascular Risk Factors in Mexican Women | Medicaweb, S.A.C.V. | Observational | Not yet recruiting | Cardiovascular Risk Factors, Cardiovascular Diseases | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863674) |
| October 6, 2026 | NCT07861100 | A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular... | Novo Nordisk A/S | Phase 3 | Not yet recruiting | Cardiovascular Risk, Obesity | 8,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07861100) |
| October 2, 2026 | NCT07856199 | Pudendal Atherosclerosis by IVUS-NIRS in Men With Coronary Artery Disease | Hospital Central Militar | Not applicable | Recruiting | Coronary Artery Disease, Erectile Dysfunction, Atherosclerosis | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07856199) |
| September 25, 2026 | NCT07841015 | A Study to Learn More About How Well Finerenone Works in Real-world in People With Type 2 Diabetes and Chronic Kidney Disease in Primary... | Bayer | Observational | Not yet recruiting | Type 2 Diabetes, Chronic Kidney Disease (CKD) Stages G2 to G3b | 800 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07841015) |
| September 22, 2026 | NCT07835360 | Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Observational | Recruiting | Obesity (Disorder), Type 2 Diabetes Mellitus | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07835360) |
| September 14, 2026 | NCT07818369 | Synbiotic LA-5 and Agave Inulin for Mild Cognitive Impairment | Anahuac University | Not applicable | Recruiting | Cognitive Impairment | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07818369) |
| September 14, 2026 | NCT07817875 | Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12... | Eli Lilly and Company | Phase 3 | Recruiting | Obesity | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07817875) |
| September 11, 2026 | NCT07815743 | Meniscal Repair Augmented With Leukocyte-Poor Platelet-Rich Plasma: A Prospective Comparative Clinical Study | Universidad Autonoma de Nuevo Leon | Not applicable | Not yet recruiting | Meniscal Tears | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07815743) |
| September 9, 2026 | NCT07811193 | A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With... | Vividion Therapeutics, Inc. | Phase 2 | Recruiting | Colorectal Adenocarcinoma | 140 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07811193) |

## Sites with the most of these trials

Sites as the records name them, organizations only.

| Site | City | Trials |
| --- | --- | --- |
| Centro de Investigacion Clinica de Oaxaca | Oaxaca City | 26 |
| Instituto Nacional de Cancerologia | Mexico City | 16 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | Mexico City | 16 |
| Scientia Investigacion Clinica S.C. | Chihuahua City | 15 |
| Medical Care and Research SA de CV | Mérida | 14 |
| CIO - Centro de Inmuno-Oncología de Occidente | Guadalajara | 13 |
| Clinical Research Institute S.C. | Tlalnepantla | 12 |
| Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán | Mexico City | 12 |
| Arké SMO S.A de C.V | Veracruz | 11 |
| Higiea Oncologia | Mexico City | 10 |
| Centro de Investigación Clinica Chapultepec | Mexico City | 10 |
| Centro de Investigacion Clinica Chapultepec | Morelia | 10 |
| Laboratorio de Patología Clínica del Hospital Universitario "Dr. José Eleuterio González" | Monterrey | 9 |
| Instituto Nacional de Cancerología | Mexico City | 9 |
| Hospital Civil Fray Antonio Alcalde | Guadalajara | 9 |
| Instituto Nacional de Cardiologia Ignacio Chavez | Mexico City | 8 |
| Centro de Estudios de Investigacion Metabolicos y Cardiovasculares, S.C. | Ciudad Madero | 8 |
| Kohler & Milstein Research S.A. De C.V. | Mérida | 8 |
| Health Pharma Professional Research S.A. de C.V: | Mexico City | 8 |
| Hospital Universitario Dr Jose Eleuterio Gonzalez | Monterrey | 8 |
| Centenario Hospital Miguel Hidalgo | Aguascalientes | 7 |
| Instituto Nacional De Cancerologia de Mexico | Mexico City | 7 |
| Hospital Civil de Guadalajara Fray Antonio Alcalde | Guadalajara | 7 |
| Clinstile, S.A. de C.V. | México | 7 |
| Clinstile S.A. de C.V. | México | 6 |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 1 |
| Phase 1 | 4 |
| Phase 1/2 | 13 |
| Phase 2 | 61 |
| Phase 2/3 | 22 |
| Phase 3 | 232 |
| Phase 4 | 17 |
| Not applicable | 110 |
| Observational | 89 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Obesity | 31 |
| Carcinoma, Non-Small-Cell Lung | 27 |
| Diabetes Mellitus, Type 2 | 22 |
| Breast Neoplasms | 19 |
| Overweight | 16 |
| Renal Insufficiency, Chronic | 15 |
| Lung Neoplasms | 14 |
| Heart Failure | 13 |
| Neoplasms | 12 |
| COVID-19 | 10 |
| Lung Diseases | 9 |
| Ovarian Neoplasms | 9 |
| Diabetes Mellitus | 9 |
| Prostatic Neoplasms | 8 |
| Colorectal Neoplasms | 8 |
| Lupus Erythematosus, Systemic | 8 |
| Neoplasm Metastasis | 8 |
| Pulmonary Disease, Chronic Obstructive | 8 |
| Cardiovascular Diseases | 7 |
| Asthma | 7 |
| Alzheimer Disease | 7 |
| Depression | 7 |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 6 |
| Hypertension | 6 |
| Colitis, Ulcerative | 6 |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| [AstraZeneca](https://specstream.ai/data/clinical-trials/company/astrazeneca) | 29 |
| [Merck Sharp & Dohme LLC](https://specstream.ai/data/clinical-trials/company/merck-sharp-and-dohme-llc) | 28 |
| [Eli Lilly and Company](https://specstream.ai/data/clinical-trials/company/eli-lilly-and-company) | 28 |
| [Hoffmann-La Roche](https://specstream.ai/data/clinical-trials/company/hoffmann-la-roche) | 20 |
| [Bristol-Myers Squibb](https://specstream.ai/data/clinical-trials/company/bristol-myers-squibb) | 19 |
| [Boehringer Ingelheim](https://specstream.ai/data/clinical-trials/company/boehringer-ingelheim) | 19 |
| [Pfizer](https://specstream.ai/data/clinical-trials/company/pfizer) | 17 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 16 |
| Instituto Nacional de Cancerologia de Mexico | 12 |
| Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 11 |
| [GlaxoSmithKline](https://specstream.ai/data/clinical-trials/company/glaxosmithkline) | 10 |
| Universidad Autonoma de Nuevo Leon | 10 |
| Instituto Mexicano del Seguro Social | 9 |
| Hospital Civil de Guadalajara | 9 |
| Instituto de Oftalmología Fundación Conde de Valenciana | 8 |
| [Janssen Research & Development, LLC](https://specstream.ai/data/clinical-trials/company/janssen-research-and-development-llc) | 8 |
| Hospital Universitario Dr. Jose E. Gonzalez | 8 |
| Universidad Autonoma de Baja California | 7 |
| [Bayer](https://specstream.ai/data/clinical-trials/company/bayer) | 7 |
| [Sanofi](https://specstream.ai/data/clinical-trials/company/sanofi) | 6 |
| National Institute of Cancerología | 6 |
| University of Guadalajara | 5 |
| [Novo Nordisk A/S](https://specstream.ai/data/clinical-trials/company/novo-nordisk-a-s) | 5 |
| Instituto Nacional de Rehabilitacion | 4 |
| SWOG Cancer Research Network | 4 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pediatric gastroenterology practices in the United States](https://specstream.ai/data/businesses/pediatric-gastroenterology-practices/united-states)
- [Ski resorts in the United States](https://specstream.ai/data/businesses/ski-resorts/united-states)
- [Welding companies in the United States](https://specstream.ai/data/businesses/welding-companies/united-states)
- [Bar and grill restaurants in the United States](https://specstream.ai/data/businesses/bar-and-grill-restaurants/united-states)
- [Credit and debt counseling services in the United States](https://specstream.ai/data/businesses/credit-and-debt-counseling-services/united-states)
- [Forestry services in the United States](https://specstream.ai/data/businesses/forestry-services/united-states)
